Literature DB >> 7469493

The development and prognosis of chronic intoxication by tetrachlordibenzo-p-dioxin in men.

J Pazderova-Vejlupková, E Lukás, M Nĕmcova, J Pícková, L Jirásek.   

Abstract

During 1965 to 1968, 80 workers who had been engaged in the production of 2, 4, 5-sodium trichlorphenoxyacetate and butylester of trichlorphenoxyacetate acid became ill. The cause of the illness was 2, 4, 7, 8-tetrachlordibenzo-p-dioxin. A 10-yr study has been conducted for 55 exposed individuals. The majority of the patients developed chloracne, and 11 manifested porphyria cutanea tarda. Approximately one-half of the patients suffered from metabolic disturbances, i.e., pathologically elevated lipids with abnormalities in the lipoprotein spectrum, and two-fifths of the patients had pathological changes in the glucose tolerance test. One-third of the patients had biochemical deviations indicative of a mild liver lesion. Histological examination revealed light steatosis, or periportal fibrosis, or activation of Kupffer cells. Fluorescence of the liver tissues was present in ultraviolet light. In 17 persons symptoms of nervous system focal damage existed, with predominance of peripheral neuron lesion of the lower extremities (verified by EMG examination). The majority of patients suffered from various psychological disorders. As of this date, two patients have died of bronchogenic lung carcinoma; one of liver cirrhosis; one of a rapidly developed, extremely unusual type of atherosclerosis precipue cerebri; and two patients have died in traffic accidents. The conditions of most other patients have improved.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7469493     DOI: 10.1080/00039896.1981.10667598

Source DB:  PubMed          Journal:  Arch Environ Health        ISSN: 0003-9896


  24 in total

Review 1.  Endocrine-disrupting chemicals and fatty liver disease.

Authors:  Charles E Foulds; Lindsey S Treviño; Brian York; Cheryl L Walker
Journal:  Nat Rev Endocrinol       Date:  2017-05-19       Impact factor: 43.330

2.  Immunological abnormalities 17 years after accidental exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  A M Jennings; G Wild; J D Ward; A M Ward
Journal:  Br J Ind Med       Date:  1988-10

3.  Lipid abnormalities in workers exposed to dioxin.

Authors:  J V Martin
Journal:  Br J Ind Med       Date:  1984-05

4.  Perspectives in occupational dermatology.

Authors:  C G Mathias; H I Maibach
Journal:  West J Med       Date:  1982-12

Review 5.  Unmetabolisable polyhalogenated compounds: implications for mammalian and other vertebrate species.

Authors:  W R Jondorf
Journal:  Vet Res Commun       Date:  1983-12       Impact factor: 2.459

Review 6.  Immunologic effects of TCDD exposure in humans.

Authors:  A P Knutsen
Journal:  Bull Environ Contam Toxicol       Date:  1984-12       Impact factor: 2.151

7.  Angiosarcoma, porphyria cutanea tarda, and probable chloracne in a worker exposed to waste oil contaminated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  R McConnell; K Anderson; W Russell; K E Anderson; R Clapp; E K Silbergeld; P J Landrigan
Journal:  Br J Ind Med       Date:  1993-08

8.  Porphyrin studies in TCDD-exposed workers.

Authors:  D Jung; J Konietzko; G Reill-Konietzko; A Muttray; H J Zimmermann-Hölz; M Doss; H Beck; L Edler; A Kopp-Schneider
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

9.  Peri- and postnatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: effects on physiological development, reflexes, locomotor activity and learning behaviour in Wistar rats.

Authors:  R Thiel; E Koch; B Ulbrich; I Chahoud
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

10.  Dioxin exposure and non-malignant health effects: a mortality study.

Authors:  A C Pesatori; C Zocchetti; S Guercilena; D Consonni; D Turrini; P A Bertazzi
Journal:  Occup Environ Med       Date:  1998-02       Impact factor: 4.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.